Doctors Note Logo

Published on: 3/12/2026

Still Depressed? Why Your Brain Is Resisting & New Spravato Treatment Steps

If you remain depressed after trying antidepressants, you may be dealing with treatment resistant depression related to glutamate pathway issues, stress driven brain changes, medical or genetic factors, or misdiagnosis; there are several factors to consider, and the details below can shape your next steps.

Spravato esketamine nasal spray is a clinic based, rapid acting option for eligible adults that is used with an oral antidepressant and requires evaluation, enrollment, monitored induction and maintenance visits, and integration with therapy and lifestyle care, with risks and urgent warning signs explained below.

answer background

Explanation

Still Depressed? Why Your Brain Is Resisting & New Spravato Treatment Steps

If you've been treated for depression but still don't feel better, you are not alone. Many people try one or even several antidepressants and continue to struggle. This experience is often called treatment-resistant depression (TRD). It does not mean you have failed. It means your brain may need a different approach.

In recent years, a newer option called Spravato treatment has offered hope for people whose depression has not improved with standard medications. Understanding why your brain may be "resisting" treatment—and what new steps are available—can help you make informed decisions with your doctor.


Why Some Depression Doesn't Respond to Standard Treatment

Traditional antidepressants (like SSRIs and SNRIs) mainly work on brain chemicals such as serotonin and norepinephrine. For many people, these medications are effective. But not everyone responds.

Here are some common reasons why depression may persist:

1. Brain Chemistry Is More Complex Than We Thought

Depression does not involve only serotonin. Other systems—especially glutamate, the brain's main excitatory neurotransmitter—also play a major role. Standard antidepressants don't directly target glutamate.

2. Chronic Stress Changes the Brain

Long-term stress can:

  • Reduce connections between brain cells
  • Shrink areas involved in mood regulation
  • Disrupt communication between brain regions

Traditional antidepressants may not fully reverse these changes.

3. Inflammation and Medical Factors

Underlying issues like:

  • Thyroid disorders
  • Chronic inflammation
  • Sleep disorders
  • Substance use
  • Hormonal imbalances

can make depression harder to treat.

4. Genetics

Some people metabolize medications differently due to genetic factors. This can affect how well a drug works or how many side effects occur.

5. Misdiagnosis

Conditions such as bipolar disorder, PTSD, ADHD, or anxiety disorders may overlap with depression. If the root condition isn't properly identified, treatment may fall short.

If you're unsure whether your symptoms align with depression or something related, taking a free Depression symptom checker can help you identify patterns and better articulate what you're experiencing when you speak with your healthcare provider.


What Is Spravato Treatment?

Spravato treatment is a prescription nasal spray containing esketamine, a form of ketamine. It was approved by the U.S. Food and Drug Administration (FDA) for adults with treatment-resistant depression and for some individuals with major depressive disorder who have suicidal thoughts.

Unlike traditional antidepressants, Spravato treatment works on the glutamate system, specifically targeting NMDA receptors in the brain.

This different mechanism may help:

  • Restore communication between brain cells
  • Promote new neural connections
  • Improve mood more rapidly than standard medications

Spravato treatment is not a first-line medication. It is typically considered after at least two other antidepressants have not worked adequately.


How Spravato Treatment Works

Spravato treatment is administered as a nasal spray in a certified medical office or clinic.

Here's what makes it different:

  • It acts on glutamate pathways
  • It may work within hours to days (faster than traditional antidepressants)
  • It is always used along with an oral antidepressant
  • It must be given under medical supervision

After receiving Spravato treatment, patients remain in the clinic for monitoring—usually about two hours. This is because the medication can temporarily cause:

  • Dizziness
  • Dissociation (feeling detached)
  • Increased blood pressure
  • Nausea

These effects typically resolve the same day.


What to Expect: Step-by-Step

If your doctor recommends Spravato treatment, here's the general process:

Step 1: Evaluation

Your healthcare provider will:

  • Confirm treatment-resistant depression
  • Review past medications
  • Assess medical history
  • Check for contraindications (like certain vascular conditions)

Step 2: Enrollment in a Certified Program

Spravato treatment is available only through a restricted distribution system to ensure safe administration and monitoring.

Step 3: Induction Phase

  • Twice-weekly treatments for about 4 weeks
  • Dose adjusted based on response and tolerance

Step 4: Maintenance Phase

  • Weekly treatments for a month
  • Then possibly every 1–2 weeks depending on progress

Your schedule may vary based on how you respond.


Is Spravato Treatment Effective?

Clinical trials have shown that Spravato treatment can significantly reduce depressive symptoms in people who have not responded to other antidepressants.

Some key findings from large, controlled studies:

  • Faster improvement in depressive symptoms compared to placebo plus oral antidepressant
  • Reduction in suicidal thoughts in some patients
  • Sustained improvement with maintenance treatment

However, it does not work for everyone. Some patients see major improvement. Others see partial improvement. A smaller group may not respond.

That's why close follow-up with your doctor is essential.


Who May Be a Good Candidate?

Spravato treatment may be appropriate if:

  • You've tried at least two antidepressants without adequate relief
  • You are currently experiencing moderate to severe depression
  • You are able to attend in-clinic appointments
  • You do not have uncontrolled high blood pressure or certain vascular conditions

It is not suitable for everyone, including individuals with certain aneurysms or a history of specific vascular diseases. A thorough medical review is required.


Risks and Considerations

While Spravato treatment is promising, it is not a simple fix.

Potential risks include:

  • Temporary dissociation
  • Increased blood pressure
  • Sedation
  • Potential for misuse (which is why it is tightly regulated)

Because of these risks, it must be administered under medical supervision.

It is also important to understand that Spravato treatment works best as part of a comprehensive plan, which may include:

  • Ongoing therapy (such as cognitive behavioral therapy)
  • Lifestyle changes (sleep, exercise, nutrition)
  • Social support
  • Management of other medical conditions

Why a Multi-Layered Approach Matters

Depression is rarely caused by one single factor. Even when Spravato treatment improves brain signaling, recovery often requires:

  • Addressing trauma
  • Rebuilding daily structure
  • Improving sleep quality
  • Reducing alcohol or substance use
  • Treating anxiety or other coexisting conditions

Medication can help stabilize mood. But long-term improvement often requires deeper work.


When to Seek Immediate Help

If you are experiencing:

  • Thoughts of harming yourself
  • Thoughts of harming others
  • Severe hopelessness
  • Sudden mood changes with risky behavior

You should seek immediate medical attention or contact emergency services. These symptoms can be life-threatening and require urgent care.

Always speak to a doctor about symptoms that feel severe, worsening, or dangerous.


A Practical Next Step

If you're still feeling depressed despite treatment:

  1. Review your full medical and psychiatric history with your doctor.
  2. Ask whether your condition qualifies as treatment-resistant depression.
  3. Discuss whether Spravato treatment could be appropriate.
  4. Consider therapy if you are not currently in counseling.
  5. Use a free Depression symptom checker to organize your symptoms and track changes before your next appointment.

The Bottom Line

If your depression hasn't improved, it does not mean you are broken or beyond help. It may mean your brain needs a different strategy.

Spravato treatment represents a newer, science-backed option for people whose depression has resisted standard medications. By targeting a different brain system, it offers a new pathway toward recovery.

That said, it is not a cure-all. It requires careful screening, in-clinic monitoring, and ongoing medical oversight. The best outcomes happen when medication is combined with therapy and healthy lifestyle changes.

Most importantly: do not try to manage severe depression alone. Speak to a qualified healthcare professional about any persistent, worsening, or potentially life-threatening symptoms. There are options—and asking about them is a strong and practical step forward.

(References)

  • * Chang H, Han S, Chang L, Hu J, Liu D. Neurobiology of Treatment-Resistant Depression: Pathophysiology and Therapeutic Strategies. Front Psychiatry. 2022 Mar 30;13:854938. doi: 10.3389/fpsyt.2022.854938. PMID: 35432655; PMCID: PMC9004122.

  • * Singh A, Singh AK, Singh AP, Singh B, Singh S, Agrawal V. Efficacy and Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: A Systematic Review and Meta-Analysis. Cureus. 2023 Apr 1;15(4):e36979. doi: 10.7759/cureus.36979. PMID: 37131806; PMCID: PMC10150935.

  • * Krystal JH, Sanacora G, Duman RS. Mechanisms of Ketamine and Esketamine in Treatment-Resistant Depression. Neuropsychopharmacology. 2022 Oct;47(10):1786-1798. doi: 10.1038/s41386-022-01402-4. Epub 2022 Aug 23. PMID: 35999335; PMCID: PMC9528659.

  • * Papakostas GI, Katragkou A, Ilias I, Psaridi M, Chatzigeorgiou G. Clinical Guidance for the Use of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression: A Narrative Review. Adv Ther. 2023 Feb;40(2):494-511. doi: 10.1007/s12325-022-02384-z. Epub 2022 Nov 22. PMID: 36414774; PMCID: PMC9936894.

  • * Hameed U, Nisar A, Khawaja S, Khan AA, Rind B, Gul M, Khan AR. Pharmacological and Nonpharmacological Treatments for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Cureus. 2024 Jan 13;16(1):e52187. doi: 10.7759/cureus.52187. PMID: 38352601; PMCID: PMC10864273.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Learn more about diseases

Depression

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.